MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group (2022)
https://pubmed.ncbi.nlm.nih.gov/35609977/

Morphological characteristics of sacroiliac joint MRI lesions in axial spondyloarthritis and control subjects (2022)
https://pubmed.ncbi.nlm.nih.gov/34097000/

Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain (2022)
https://pubmed.ncbi.nlm.nih.gov/35739562/

Enthesitis in patients with psoriatic arthritis and axial spondyloarthritis – data from the Danish nationwide DANBIO registry (2022)
https://pubmed.ncbi.nlm.nih.gov/35027245/

Anatomic Distribution of Sacroiliac Joint Lesions on Magnetic Resonance Imaging in Patients With Axial Spondyloarthritis and Control Subjects: A Prospective Cross-Sectional Study, Including Postpartum Women, Patients With Disc Herniation, Cleaning Staff, Runners, and Healthy Individuals (2021)
https://pubmed.ncbi.nlm.nih.gov/33002333/

Data-driven definitions for active and structural MRI lesions in the sacroiliac joint in spondyloarthritis and their predictive utility (2021)
https://pubmed.ncbi.nlm.nih.gov/33523107/

Arthritis and enthesitis in the hip and pelvis region in spondyloarthritis – OMERACT validation of two whole-body MRI methods (2021)
https://pubmed.ncbi.nlm.nih.gov/34140185/

Development and Validation of 3 Preliminary MRI Sacroiliac Joint Composite Structural Damage Scores in a 5-year Longitudinal Axial Spondyloarthritis Study (2021)
https://pubmed.ncbi.nlm.nih.gov/33858979/

The Value of Magnetic Resonance Imaging for Assessing Disease Extent and Prediction of Relapse in Early Peripheral Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33982902/

Imaging in psoriatic arthritis: Status and recent advances (2021)
https://pubmed.ncbi.nlm.nih.gov/34016527/

Whole-body Magnetic Resonance Imaging in Psoriatic Arthritis, Rheumatoid Arthritis, and Healthy Controls: Interscan, Intrareader, and Interreader Agreement and Distribution of Lesions (2021)
https://pubmed.ncbi.nlm.nih.gov/32541078/

Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial (2020)
https://pubmed.ncbi.nlm.nih.gov/31813637/

Whole-body Magnetic Resonance Imaging Inflammation in Peripheral Joints and Entheses in Axial Spondyloarthritis: Distribution and Changes during Adalimumab Treatment (2020)
https://pubmed.ncbi.nlm.nih.gov/30936290/

Test-retest repeatability of the apparent diffusion coefficient in sacroiliac joint MRI in patients with axial spondyloarthritis and healthy individuals (2020)
https://pubmed.ncbi.nlm.nih.gov/32206343/

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration (2020)
https://pubmed.ncbi.nlm.nih.gov/32950963/

The utility of magnetic resonance imaging lesion combinations in the sacroiliac joints for diagnosing patients with axial spondyloarthritis. A prospective study of 204 participants including post-partum women, patients with disc herniation, cleaning staff, runners and healthy persons (2020)
https://pubmed.ncbi.nlm.nih.gov/32240310/

MRI of the sacroiliac joints: what is and what is not sacroiliitis? (2020)
https://pubmed.ncbi.nlm.nih.gov/32453038/

Scoring magnetic resonance imaging (MRI) inflammation and structural lesions in sacroiliac joints of patients with axial spondyloarthritis: assessment of all MRI slices of the cartilaginous compartment versus standardized six or five slices (2020)
https://pubmed.ncbi.nlm.nih.gov/31847676/

Atlas of the OMERACT Heel Enthesitis MRI Scoring System (HEMRIS) (2020)
https://pubmed.ncbi.nlm.nih.gov/32568094/

Efficacy and safety of cannabidiol followed by an open label add-on of tetrahydrocannabinol for the treatment of chronic pain in patients with rheumatoid arthritis or ankylosing spondylitis: protocol for a multicentre, randomised, placebo-controlled study (2019)
https://pubmed.ncbi.nlm.nih.gov/31167870/

The need for comparative data in spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30670074/

Extremely poor patient-reported outcomes are associated with lack of clinical response and decreased retention rate of tumour necrosis factor inhibitor treatment in patients with axial spondyloarthritis (2019)
https://pubmed.ncbi.nlm.nih.gov/30102111/

Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration (2019)
https://pubmed.ncbi.nlm.nih.gov/31431486/

Canada-Denmark MRI scoring system of the spine in patients with axial spondyloarthritis: updated definitions, scoring rules and inter-reader reliability in a multiple reader setting (2019)
https://pubmed.ncbi.nlm.nih.gov/31673422/

Inflammatory and structural changes in vertebral bodies and posterior elements of the spine in axial spondyloarthritis: construct validity, responsiveness and discriminatory ability of the anatomy-based CANDEN scoring system in a randomised placebo-controlled trial (2018)
https://pubmed.ncbi.nlm.nih.gov/29556419/